Correlation Between Silo Pharma and OKYO Pharma

Can any of the company-specific risk be diversified away by investing in both Silo Pharma and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silo Pharma and OKYO Pharma Ltd, you can compare the effects of market volatilities on Silo Pharma and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and OKYO Pharma.

Diversification Opportunities for Silo Pharma and OKYO Pharma

-0.13

Correlation Coefficient

Silo Pharma  OKYO Pharma

Good diversification

The 3 months correlation between Silo and OKYO is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Silo Pharma i.e., Silo Pharma and OKYO Pharma go up and down completely randomly.

Pair Corralation between Silo Pharma and OKYO Pharma

Given the investment horizon of 90 days Silo Pharma is expected to generate 2.19 times more return on investment than OKYO Pharma. However, Silo Pharma is 2.19 times more volatile than OKYO Pharma Ltd. It trades about 0.14 of its potential returns per unit of risk. OKYO Pharma Ltd is currently generating about 0.16 per unit of risk. If you would invest  82.00  in Silo Pharma on December 18, 2024 and sell it today you would earn a total of  57.00  from holding Silo Pharma or generate 69.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Silo Pharma  vs.  OKYO Pharma Ltd

Silo Pharma

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Silo Pharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal essential indicators, Silo Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

OKYO Pharma

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in OKYO Pharma Ltd are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, OKYO Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Silo Pharma and OKYO Pharma

The main advantage of trading using opposite Silo Pharma and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.

The idea behind Silo Pharma and OKYO Pharma Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.